Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

5451 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-12

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vaccine uptake in the United States is lower in rural areas, especially for HPV vaccine. Reminder/recall has been identified as an effective strategy to increase vaccination rates. This study will assess the impact by rurality of vaccine reminder notices sent via the parent's preferred method of communication on HPV vaccination among 12 year-old patients in a regional healthcare system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Electronic Messaging to Increase Human Papillomavirus Vaccine Utilization and Adherence Among College Students

NCT01568515

Patient Compliance Health Knowledge, Attitudes, Practice

COMPLETED EARLY_PHASE1

HPV IIS Reminder/Recall- New York State

NCT03057379

Reminder Systems

COMPLETED NA

Usability of HPV Vaccine Reminders

NCT03987490

Human Papilloma Virus (HPV)

COMPLETED NA

Text Reminders to Immunize in a Managed Care Organization

NCT01806714

Human Papilloma Virus

COMPLETED NA

State Immunization Information Systems to Improve HPV Vaccination Rates

NCT02993965

Vaccine Human Papiloma Virus Vaccine HPV Vaccine +5 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Papillomavirus Vaccines

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enhanced Reminder

Group Type EXPERIMENTAL

Reminder Sent Via Preferred Method of Communication

Intervention Type BEHAVIORAL

Parents of 12 year-old patients due for ≥1 adolescent vaccine will receive a vaccine reminder notice every other month via their preferred method of communication (text message, email, mailed letter) until the adolescent receives all recommended vaccines, opts out of reminders, or turns 13.

Standard of Care

Group Type OTHER

Reminder Sent Via Mailed Letter

Intervention Type BEHAVIORAL

Parents of 12 year-old patients due for ≥1 adolescent vaccine will receive a mailed vaccine reminder letter every other month until the adolescent receives all recommended vaccines, opts out of reminders, or turns 13.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Reminder Sent Via Preferred Method of Communication

Parents of 12 year-old patients due for ≥1 adolescent vaccine will receive a vaccine reminder notice every other month via their preferred method of communication (text message, email, mailed letter) until the adolescent receives all recommended vaccines, opts out of reminders, or turns 13.

Intervention Type BEHAVIORAL

Reminder Sent Via Mailed Letter

Parents of 12 year-old patients due for ≥1 adolescent vaccine will receive a mailed vaccine reminder letter every other month until the adolescent receives all recommended vaccines, opts out of reminders, or turns 13.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Marshfield Clinic Health System patient aged 12 years with at least one preventive visit or two evaluation \& management visits with a Marshfield Clinic Health System provider in the last 36 months
* Due for at least one adolescent vaccine (HPV, MenACWY, Tdap)

Exclusion Criteria

* Primary care provider is not affiliated with Marshfield Clinic Health System
* Opted out of Marshfield Clinic Health System vaccine reminder notifications
* Missing or invalid contact information
* Deceased

Minimum Eligible Age

12 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No